U.S. Blood Cancer Diagnostics Market Size & Outlook

Name: U.S. Blood Cancer Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The blood cancer diagnostics market in the United States is expected to reach a projected revenue of US$ 4,617.0 million by 2030. A compound annual growth rate of 5.5% is expected of the United States blood cancer diagnostics market from 2025 to 2030.

Clinical Diagnostics
- Cancer Diagnostics
  - Blood Cancer Diagnostics Market Outlook

U.S. blood cancer diagnostics product outlook (Revenue, USD million, 2018-2030)
- Instruments
- Assay Kits and Reagents
U.S. blood cancer diagnostics test outlook (Revenue, USD million, 2018-2030)
- Blood Tests
- Imaging Tests
- Biopsy
- Molecular Test
U.S. blood cancer diagnostics enduse outlook (Revenue, USD million, 2018-2030)
- Hospitals and Clinics
- Diagnostic Labs
- Research Institutes

U.S. Blood Cancer Diagnostics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!